PUBLICATIONS · 15546135
High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2005 Apr
- First author
- Pritchard J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pritchard J
- type
- Author
- name
- Cotterill SJ
- type
- Author
- name
- Germond SM
- type
- Author
- name
- Imeson J
- type
- Author
- name
- de Kraker J
- type
- Author
- name
- Jones DR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pritchard J
- type
- Author
- name
- Cotterill SJ
- type
- Author
- name
- Germond SM
- type
- Author
- name
- Imeson J
- type
- Author
- name
- de Kraker J
- type
- Author
- name
- Jones DR
- type
- Author
- bibliography ids
- nci-bib-64a17dfa175b2bcf5a3d372a
- book metadata
- content sha256
- 4d2f6e8b5fed82c378e0a301c5775d5486460dbcedf8ad9632c02dbd4a5072c6
- document type
- citation
- dois
- 10.1002/pbc.20219
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15546135
- immutable id
- pubmed:15546135@4d2f6e8b5fed82c378e0a301c5775d5486460dbcedf8ad9632c02dbd4a5072c6
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- Source null
- issn print
- 1545-5009
- issue
- 4
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 348-57
- volume
- 44
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15546135
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 7cde1f6d3f6955305610da9fcccec4b003215196f70ec7909c1ffb54a0e03bb8
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2005 Apr
- precision
- month
- year
- 2005
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.
Preserved source evidence · Not medical advice
Triangle